Kay Mark A 4
4 · LogicBio Therapeutics, Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
Kay Mark A
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-01+2,199→ 2,199 total - Exercise/Conversion
Restricted Stock Units
2021-01-01−2,199→ 0 total→ Common Stock (2,199 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
- [F2]All of the RSUs vested on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan.